Provided by Tiger Fintech (Singapore) Pte. Ltd.

Dermata Therapeutics Inc

0.7290
+0.01902.68%
Post-market: 0.73000.0010+0.14%18:52 EDT
Volume:44.85K
Turnover:32.03K
Market Cap:3.96M
PE:-0.09
High:0.7300
Open:0.7200
Low:0.7000
Close:0.7100
Loading ...
May 16, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 16, 2022

Major Issues Report

8-K - Current report
May 11, 2022

Correspondence

CORRESP [Cover] - Correspondence
May 05, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
May 04, 2022

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Apr 25, 2022

Major Issues Report

8-K - Current report
Mar 28, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 28, 2022

Major Issues Report

8-K - Current report
Mar 02, 2022

Major Issues Report

8-K - Current report
Feb 07, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Feb 04, 2022

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Feb 04, 2022

Major Issues Report

8-K - Current report
Feb 04, 2022

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Jan 13, 2022

Major Issues Report

8-K - Current report
Dec 10, 2021

Major Issues Report

8-K - Current report
Dec 10, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Nov 26, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Sep 01, 2021

Major Issues Report

Dermata Therapeutics, Inc.
Sep 01, 2021

Statement Of Changes In Beneficial Ownership

3 - Initial statement of beneficial ownership of securities
Sep 01, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities